FindTrial
Sign In

Mechanism of intestinal flora and metabolites on allergic rhinitis-asthma syndrome in children by regulating T cell subsets

Mechanism of intestinal flora and metabolites on allergic rhinitis-asthma syndrome in children by regulating T cell subsets

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500098263
Enrollment
Unknown
Registered
2025-03-05
Start date
2025-03-15
Completion date
Unknown
Last updated
2025-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Combined Allergic Rhinitis and Asthma Syndrome(CARAS)

Interventions

Combined Allergic Rhinitis and Asthma Syndrome group:NA
Allergic Rhinitis group:NA
Healthy Control group:NA

Sponsors

Wuxi children's hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 11 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for asthma in the "Guidelines for Diagnosis and Prevention of Childhood Bronchial Asthma"; 2. Meet the diagnostic criteria for allergic rhinitis in the "Guidelines for Diagnosis and Treatment of Allergic Rhinitis in Children"; 3. Children aged 6-11 years old.

Exclusion criteria

Exclusion criteria: 1.acute severe asthma exacerbations; 2.Patients with other acute and chronic diseases, such as cardiopulmonary and renal insufficiency, severe congenital diseases, and mental patients;

Design outcomes

Primary

MeasureTime frame
FeNO;Serum total IgE and specific IgE;Percentage of eosinophilia;FEV1/FVC;—

Countries

China

Contacts

Public ContactGuo Yun

Wuxi children's hospital

lu-02cy@163.com+86 510 85350591

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026